Genentech's gutsy move: Biotech giant snags potential half-billion-dollar deal with UK microbiome company

In its second microbiome deal over the past month, Genentech and partner Microbiotica will tap artificial intelligence to identify ways to use the gut's own environment to attack inflammatory bowel disease.

Source: bizjournals.com Health Care:Biotechnology headlines - June 6, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news